BECONASE Drug Patent Profile
✉ Email this page to a colleague
When do Beconase patents expire, and when can generic versions of Beconase launch?
Beconase is a drug marketed by Glaxosmithkline and is included in two NDAs.
The generic ingredient in BECONASE is beclomethasone dipropionate monohydrate. There are twenty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the beclomethasone dipropionate monohydrate profile page.
Summary for BECONASE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 65 |
Clinical Trials: | 4 |
Patent Applications: | 5,329 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for BECONASE |
What excipients (inactive ingredients) are in BECONASE? | BECONASE excipients list |
DailyMed Link: | BECONASE at DailyMed |
Recent Clinical Trials for BECONASE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
West Penn Allegheny Health System | Phase 4 |
University Health Network, Toronto | N/A |
Glaucoma Research Society of Canada | N/A |
US Patents and Regulatory Information for BECONASE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | BECONASE | beclomethasone dipropionate | AEROSOL, METERED;NASAL | 018584-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | BECONASE AQ | beclomethasone dipropionate monohydrate | SPRAY, METERED;NASAL | 019389-001 | Jul 27, 1987 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BECONASE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline | BECONASE | beclomethasone dipropionate | AEROSOL, METERED;NASAL | 018584-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Glaxosmithkline | BECONASE | beclomethasone dipropionate | AEROSOL, METERED;NASAL | 018584-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for BECONASE
See the table below for patents covering BECONASE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Netherlands | 7305438 | ⤷ Try a Trial | |
Germany | 7537646 | ⤷ Try a Trial | |
Australia | 5466073 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |